Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @HarvardMIT_CRS
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @HarvardMIT_CRS
-
Prikvačeni tweet
The
@HarvardMIT_CRS#RegSci2020#RegSci fellows showcase is starting! Center co-director@ftbourgeois@BostonChildrens@Bos_CHIP introduces the sessionpic.twitter.com/n5dhX7UHVR
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Wai Cheung (Adrian) Chan, student in Chemical Biology PhD Program saves the day for
@Frank_S_David with a more biology-oriented talk on DUBs and the development of a chemoproteomic platform that could lead to discovery of new DUB inhibitors and novel therapeutic opportunities!pic.twitter.com/wB1Wb8aAQf
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
@GopalKot PhD student at T.H. Chan Harvard School of Public Health is discussing factorial clinical trial designs and potential applications@LorenzoTrippapic.twitter.com/SV2T2aQPmz
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
PhD candidate in Health Policy
@HarvardHBS Pragya Kakani discussing the safety and efficacy of off-label uses of cancer medicines in the USpic.twitter.com/TtgVPP0RP3
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Unique study led by Caroline Marra PhD student in Health Policy Management
@HarvardHBS on foundation-industry collaborations in clinical research and understanding the innovation effectspic.twitter.com/DwhelhGpLE
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Super interesting talk from Shawn Kim student
@TuftsDental on how to use data visualization & statistical methods to enhance operational efficiency of new patient screeningpic.twitter.com/bwTnUd5QTX
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Richard Huang,
#MGH pathologist talking about the future of Digital Pathology in the context of#FDAPreCert,#digitalhealth and implications for@US_FDA regulations@HarvardMIT_CRSpic.twitter.com/uzTBNoXoI8
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great morning at Regsci Doctoral Student Symp! Great research around RCT design shortcomings, methods extrapolating patient level data, and FDA precert & digital pathology Thanks students and faculty
@arieldora@Frank_S_David@ftbourgeois@PlanaDeborah@kroymyers@JoshuaLKriegerpic.twitter.com/ov2XXYYSKQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Always blown away by the quality and diversity of
#RegSci student & fellow research. Thanks again to@HarvardMIT_CRS and@HarvardHBS for sponsoring & hosting!https://twitter.com/monica_ruse/status/1224335967982694401 … – mjesto: Harvard Business School
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
MD PhD student
@PlanaDeborah@HiTSatHarvard presenting a very compelling argument for sharing individual patient data from clinical trials and how we can learn why some trials have failed and predict future outcomes@HarvardMIT_CRSpic.twitter.com/7RKZlYfDMC
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
NEW op-ed with
@weparmet@NUSL@NUSLHealth in@washingtonpost Perspective: Why we should be wary of an aggressive government response to coronavirushttps://www.washingtonpost.com/outlook/2020/02/03/why-we-should-be-wary-an-aggressive-government-response-coronavirus/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Great discussion around the study lead by
@MaryalineC on how to enrich the methods and extend the scope from@HarvardHBS faculty@KRoyMyers@arieldora and@HarvardMIT_CRS faculty@ftbourgeoisPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Fascinating talk by
@MaryalineC Health Policy PhD candidate on inadequacies in RCTs and consequences on knowledge gained and costs for society@HarvardMIT_CRSpic.twitter.com/CFdfrnfTIo
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Regsci Fellowship Director
@ftbourgeois provides intro of@HarvardMIT_CRS, including Regsci Fellowship program and a shout out to our fantastic fellows@AleAviP@RussMass20@ArfeAndrea@DrSinhaEsq@GuoXinzhoupic.twitter.com/wBjuWX4WgJ
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Starting now: Regulatory Science Student Symposium 2020!
@HarvardMIT_CRS CRS Faculty and enthusiastic mentor@arieldora welcomes us all@HarvardHBSpic.twitter.com/OWTbDwKOsc
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Harvard-MIT Center for Regulatory Science proslijedio/la je Tweet
Happening
#AroundTheHub tomorrow: Regulatory Science Student Symposium 2020@HarvardMIT_CRS,@harvard_data Industry Seminar: Dan Svirsky,@Uber, Cambridge: CyTOF Mass Cytometry#DataAnalysis Workshop Series@bluebirdbio, and Taxes for Artists@NEFA_Boston:http://bit.ly/2t4aPtqHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy
#FollowFriday! Today we spotlight another terrific@HarvardMIT_CRS@HiTSatHarvard fellow,@RussMass20! Dr. Russo completed his PhD from@UniPadova and works with Dr.@LorenzoTrippa at@DFCIDataScience#HMCRS#RegSci2020 http://rmassimiliano.github.io pic.twitter.com/XY8mQzZtD3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great 10 minute
talks from all! If you are interested in joining the @HarvardMIT_CRS team as a fellow, you're in luck! More info here:https://twitter.com/HarvardMIT_CRS/status/1215104049873399808?s=19 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@HarvardMIT_CRS@dfcidatascience fellow@AleAviP presents work on the incorporation of external data into clinical trials, including the potential for platform trials that share a single external control armpic.twitter.com/QqjgsrrC5L
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@HarvardMIT_CRS fellow and@PORTAL_Research collaborator@DrSinhaEsq presents recent work comparing@US_FDA and@EMA_News approval data for biosimilars, based on work published in@JournalGIM:https://link.springer.com/article/10.1007/s11606-019-05408-6 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Kevin Nam,
@MITLL@MIT_Innovation@newdigsMIT researcher and@HarvardMIT_CRS collaborator, presents his collaborative work on the "Dynamic Dossier in the Cloud"pic.twitter.com/uyCfnu1pDz
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Postdoctoral fellowship opportunity!